SE0301885D0 - New use IV - Google Patents

New use IV

Info

Publication number
SE0301885D0
SE0301885D0 SE0301885A SE0301885A SE0301885D0 SE 0301885 D0 SE0301885 D0 SE 0301885D0 SE 0301885 A SE0301885 A SE 0301885A SE 0301885 A SE0301885 A SE 0301885A SE 0301885 D0 SE0301885 D0 SE 0301885D0
Authority
SE
Sweden
Prior art keywords
wound healing
hsd1
inhibitor
new use
promoting wound
Prior art date
Application number
SE0301885A
Other languages
English (en)
Swedish (sv)
Inventor
Cecilia Nilsson
Catrine Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0301885A priority Critical patent/SE0301885D0/xx
Publication of SE0301885D0 publication Critical patent/SE0301885D0/xx
Priority to PCT/SE2004/000959 priority patent/WO2004112783A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0301885A 2003-06-25 2003-06-25 New use IV SE0301885D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301885A SE0301885D0 (sv) 2003-06-25 2003-06-25 New use IV
PCT/SE2004/000959 WO2004112783A1 (fr) 2003-06-25 2004-06-16 Utilisation iv

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301885A SE0301885D0 (sv) 2003-06-25 2003-06-25 New use IV

Publications (1)

Publication Number Publication Date
SE0301885D0 true SE0301885D0 (sv) 2003-06-25

Family

ID=27656620

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301885A SE0301885D0 (sv) 2003-06-25 2003-06-25 New use IV

Country Status (2)

Country Link
SE (1) SE0301885D0 (fr)
WO (1) WO2004112783A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
AR049344A1 (es) 2004-05-24 2006-07-19 Amgen Inc Inhibidores de la 11-beta-hidroxi esteroide deshidrogenasa de tipo 1
WO2006013054A1 (fr) * 2004-08-05 2006-02-09 F. Hoffmann-La Roche Ag Aminothiazoles substitués n-acyle-2-
EP1866298A2 (fr) 2005-03-31 2007-12-19 Takeda San Diego, Inc. Inhibiteurs de l'hydroxysteroide deshydrogenase
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
EP1951696A2 (fr) 2005-11-22 2008-08-06 Amgen Inc. Inhibiteurs de la 11-beta-hydroxy steroide deshydrogenase de type 1
EP3235813A1 (fr) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Dérivés aza-tétra-cycliques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10639A (en) * 1967-07-17 1977-07-22 Research Corp Method of treatment and composition containing silver sulfadiazine
ATE243203T1 (de) * 1995-04-04 2003-07-15 Texas Biotechnology Corp Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität
EP0934300B1 (fr) * 1996-10-16 2002-12-18 American Cyanamid Company Preparation d'acides ortho-sulfonamido heteraryl-hydroxamiques et leur utilisation en tant qu'inhibiteurs des metalloproteinases matricielles et de tace
SE0001899D0 (sv) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds

Also Published As

Publication number Publication date
WO2004112783A1 (fr) 2004-12-29

Similar Documents

Publication Publication Date Title
SE0301882D0 (sv) New use I
SE0301886D0 (sv) New use V
SE0301888D0 (sv) New use VII
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
DE602006010442D1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
HK1125040A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
CY1109763T1 (el) Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
EA200201276A1 (ru) Производные арилметиламина для использования в качестве ингибиторов триптазы
MXPA05010020A (es) Derivados de oxamida.
SE0301883D0 (sv) New use II
TW200600084A (en) Anti-coronavirus compounds
SE0301885D0 (sv) New use IV
SE0004101D0 (sv) New use
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
SE0301884D0 (sv) New use III
SE0002739D0 (sv) New use
ATE391710T1 (de) Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
SE0000303D0 (sv) Novel compounds